Yang L, Du L, Ge Y, Ou M, Huang W, Wang X
BMC Cardiovasc Disord. 2025; 25(1):36.
PMID: 39849369
PMC: 11756209.
DOI: 10.1186/s12872-025-04480-7.
Yu M, Cui Z, Bai Y
Mediators Inflamm. 2024; 2024:5587265.
PMID: 39723114
PMC: 11669424.
DOI: 10.1155/mi/5587265.
Banahene N, Sinha T, Shaikh S, Zin A, Khreis K, Chaudhari S
Cureus. 2024; 16(6):e61647.
PMID: 38966451
PMC: 11223570.
DOI: 10.7759/cureus.61647.
Ul Hussain H, Ashok Kumar K, Zahid M, Husban Burney M, Khan Z, Asif M
Medicine (Baltimore). 2024; 103(26):e38692.
PMID: 38941418
PMC: 11466144.
DOI: 10.1097/MD.0000000000038692.
de Liyis B, Ciaves A, Intizam M, Jusuf P, Artha I
Biomedicine (Taipei). 2024; 13(4):32-43.
PMID: 38532835
PMC: 10962536.
DOI: 10.37796/2211-8039.1425.
Association between the variability of non-high-density lipoprotein cholesterol and the neutrophil-to-lymphocyte ratio in patients with coronary heart disease.
Chen Y, Zhang S, Tao Y, Hu W, Li D, Shen X
Front Cardiovasc Med. 2023; 10:1254125.
PMID: 38075976
PMC: 10710147.
DOI: 10.3389/fcvm.2023.1254125.
Novel Hematological Parameters in the Assessment of the Extent of Cardiac Implantable Electronic Device-Related Infections.
Polewczyk M, Jachec W, Szczesniak-Stanczyk D, Polewczyk A, Tomaszewski A, Brzozowski W
J Clin Med. 2023; 12(23).
PMID: 38068550
PMC: 10707215.
DOI: 10.3390/jcm12237498.
Assessment of Inflammatory Hematological Ratios (NLR, PLR, MLR, LMR and Monocyte/HDL-Cholesterol Ratio) in Acute Myocardial Infarction and Particularities in Young Patients.
Tudurachi B, Anghel L, Tudurachi A, Sascau R, Statescu C
Int J Mol Sci. 2023; 24(18).
PMID: 37762680
PMC: 10531986.
DOI: 10.3390/ijms241814378.
Platelet-to-lymphocyte ratio a potential prognosticator in acute myocardial infarction: A prospective longitudinal study.
Wang H, Li L, Ma Y
Clin Cardiol. 2023; 46(6):632-638.
PMID: 37060180
PMC: 10270260.
DOI: 10.1002/clc.24002.
Circulating tumor necrosis factor-α, interleukin-1β, and interleukin-17A estimates increased major adverse cardiac event risk in acute myocardial infarction patients.
Guo J, Hu Z, Ren L, Zhao W, Zuo R, Guo S
J Clin Lab Anal. 2023; 37(5):e24853.
PMID: 36877748
PMC: 10098063.
DOI: 10.1002/jcla.24853.
The neutrophil-lymphocyte ratio to predict poor prognosis of critical acute myocardial infarction patients: a retrospective cohort study.
Wang W, Liu L, Ning Z, Che L, Li X
Biochem Med (Zagreb). 2023; 33(1):010702.
PMID: 36627973
PMC: 9807232.
DOI: 10.11613/BM.2023.010702.
The abnormal level and prognostic potency of multiple inflammatory cytokines in PCI-treated STEMI patients.
Zhang J, Xu H, Yao M, Jia H, Cong H
J Clin Lab Anal. 2022; 36(11):e24730.
PMID: 36245413
PMC: 9701898.
DOI: 10.1002/jcla.24730.
Serum VCAM-1 and ICAM-1 measurement assists for MACE risk estimation in ST-segment elevation myocardial infarction patients.
Yu J, Liu Y, Peng W, Xu Z
J Clin Lab Anal. 2022; 36(10):e24685.
PMID: 36045604
PMC: 9550957.
DOI: 10.1002/jcla.24685.
The Neutrophil-to-Lymphocyte Ratio Is an Important Indicator Predicting In-Hospital Death in AMI Patients.
Ji Z, Liu G, Guo J, Zhang R, Su Y, Carvalho A
Front Cardiovasc Med. 2021; 8:706852.
PMID: 34616780
PMC: 8488114.
DOI: 10.3389/fcvm.2021.706852.
Changes in the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios before and after percutaneous coronary intervention and their impact on the prognosis of patients with acute coronary syndrome.
Sheng J, Liu N, He F, Cheng C, Shen S, Sun Y
Clinics (Sao Paulo). 2021; 76:e2580.
PMID: 34378727
PMC: 8311648.
DOI: 10.6061/clinics/2021/e2580.
The correlation between PLR-NLR and prognosis in acute myocardial infarction.
Liu J, Ao W, Zhou J, Luo P, Wang Q, Xiang D
Am J Transl Res. 2021; 13(5):4892-4899.
PMID: 34150072
PMC: 8205844.
Prognostic value of neutrophil- lymphocyte count ratio (NLCR) among adult ICU patients in comparison to APACHE II score and conventional inflammatory markers: a multi center retrospective cohort study.
Zhou T, Zheng N, Li X, Zhu D, Han Y
BMC Emerg Med. 2021; 21(1):24.
PMID: 33622247
PMC: 7903782.
DOI: 10.1186/s12873-021-00418-2.
Neutrophil-Lymphocyte Ratio in Predicting Infective Endocarditis: A Case-Control Retrospective Study.
Chen Y, Ye L, Wu Y, Shen B, Zhang F, Qu Q
Mediators Inflamm. 2020; 2020:8586418.
PMID: 33354163
PMC: 7735837.
DOI: 10.1155/2020/8586418.
Addition of routine blood biomarkers to TIMI risk score improves predictive performance of 1-year mortality in patients with ST-segment elevation myocardial infarction.
Oh P, Eom Y, Moon J, Jang H, Kim T, Suh J
BMC Cardiovasc Disord. 2020; 20(1):486.
PMID: 33208092
PMC: 7672980.
DOI: 10.1186/s12872-020-01777-7.